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administered it to themselves as an abortifacient. This off-label
use as an abortifacient is particularly disturbing. Searle has
raised these concerns in various forums in the past, and we
continue to forward and refer similar reports to the Medicines
Control Council. Furthermore, our concerns have been
reiterated in a recent issue of this journaU"
We are grateful that these issues have once again been
brought to the attention of health care professionals. It is
unfortunate that indiscriminate use of the product detracts
from it's significant benefit when used appropriately as a
gastro-intestinal mucosal protectant.
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The finding of a 1+ protein on the Combur 9 reagent strips
occurred in 49 patients, of which number 41 (84%) had
transudates and 8 (16%) had exudates according to Light's
criteria. Two hundred and twenty-nine patients had 3+ protein
in their effusions, corresponding to 223 (97%) exudative and 6
(3%) transudative effusions. The finding of 2+ protein occurred
in 105 patients, consisting of 55 (52%) transudates and 50 (48%)
exudates. These findings are summarised in Table IT.
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A RAPID SCREENING TEST FOR PLEURAL
EXUDATES
To the Editor: Distinguishing between exudates and
transudates is the initial step in determining the cause of a
pleural effusion and deciding which further and often more
invasive investigations should be carried out. Although
numerous alternative methods have been suggested in the
literature/ the application of Light's criteria' is the traditional
method for making this distinction. According to these criteria,
an exudate is defined as having at least one of the following: a
pleural/serum (P/5) ratio ~ 0.5, a P/5 lactate dehydrogenase
(LDH) ratio ~ 0.6 and/or a pleural fluid LDH concentration>
200 }Ill.
In an ongoing prospective study involving consecutive
patients with pleural effusions admitted to Tygerberg Hospital,
a large number of pleural effusions of various aetiologies were
evaluated and 383 patients were included in this substudy.
Pleural effusion and serum specimens were analysed for total
protein and LDH, and classified as exudate or transudate
according to Light's criteria. The pleural fluid was tested
independently with Combur 9 (Boehringer Mannheim) urinary
reagent strips. Due to the higher protein concentrations in
pleural fluids compared with urine, a 1:10 dilution of pleural
fluid with normal saline (0.9%) was made. The reagent strip
was dipped directly into the test tube and the colour change
read after 60 seconds against the colour scales on the label. The
results were recorded as 1+ (0.3 g/l), 2+ (1.0 g/l) or 3+ (5.0
g/l). The results are summarised in Table I.
Using the finding of 1+ protein as being suggestive of a
transudative effusion, the sensitivity and specificity of the
Combur 9 test was calculated as 42% and 97%, respectively.
The corresponding positive (ppv) and negative (npv) predictive
values were 84% and 83%, respectively. Similarly, using the
finding of 3+ protein as a marker for an exudate demonstrated
a sensitivity, specificity, ppv and npv of 78%, 94%, 97% and
59%, respectively. In this way, 41 (out of 97) transudates and
223 (out of 286) exudates were correctly classified. A total of
264 (69%) of the 383 effusions were correctly classified by this
method.
Urinary reagent strips therefore provide a cheap, easy, fast
and accurate screening test to distinguish between pleural
exudates and transudates. This method should not be regarded
as a substitute for laboratory investigations, but rather as an
adjunct to the clinician's initial assessment in order to plan
further investigations and management before more definitive
tests become available.
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